North America Oxygen Concentrators Market (2025 - 2033) Size, Share & Trends Analysis Report By Product (Portable Oxygen Concentrator, Fixed Oxygen Concentrator), By Application (Home Care, Non-home Care), By Technology, By Country, And Segment Forecasts

North America Oxygen Concentrators Market Summary

The North America oxygen concentrators market size was estimated at USD 1.99 billion in 2024 and is projected to reach USD 4.72 billion by 2033, growing at a CAGR of 10.0% from 2025 to 2033. The growth is attributed to an increase in the prevalence of respiratory conditions such as COPD, asthma, and sleep apnea.

According to the 2024 National Survey by Asthma Canada, over 4.6 million people in Canada are living with asthma, including 900,000 children under 19 and 800,000 adults over 65. Asthma is the third most prevalent chronic disease in the country, with an estimated 317 new diagnoses every day and around 250 deaths annually. In addition, advancements in respiratory technology are significantly supporting market growth.

Furthermore, favorable reimbursement policies have enhanced the attractiveness of the oxygen concentrators market in North America. For instance, in March 2024, a U.S. Congressman introduced the Supplemental Oxygen Access Reform (SOAR) Act to reform and improve access to supplementary oxygen for Medicare beneficiaries. These policies have increased the adoption of oxygen concentrators in the U.S. In addition, rising healthcare spending in the U.S. and Canada is driving the demand for effective diagnosis and treatment of respiratory diseases, thereby boosting the market for oxygen concentrators.

Initiatives by public and private authorities, such as the World Health Organization's distribution of oxygen concentrators and the efforts of associations like the American Lung Association, promote awareness of respiratory diseases. Market players also employ strategies such as acquisitions, collaborations, expansions, and new product launches to extend their product offerings and geographical reach. For instance, in June 2025, Inogen launched the Voxi 5 stationary oxygen concentrator, offering an affordable, durable, and quiet continuous flow oxygen therapy solution for long-term care patients in the US, enhancing home respiratory care accessibility. The device features a compact design, caster wheels for mobility, a 3-year sieve bed warranty, and advanced filtration technology.

Market Concentration & Characteristics

The chart below illustrates the relationship between market concentration, industry characteristics, and industry participants. The X-axis represents the level of industry concentration, ranging from low to high. The y-axis represents various industry characteristics, including industry competition, impact of regulations, level of partnerships & collaborations activities, degree of innovation, and regional expansion. For instance, the North America oxygen concentrator market is slightly fragmented, with many product & service providers entering the market. The degree of innovation, the level of partnerships & collaboration activities, and the impact of regulations on the industry is high. However, the regional expansion observes moderate growth.

The industry exhibits a high degree of innovation, with companies like Inogen introducing cutting-edge products. For instance, in December 2022, Inogen received 510(k) premarket clearance from the U.S. Food and Drug Administration (FDA) for its new portable oxygen concentrator, Rove 4. This product is expected to enhance Inogen's leadership in portable oxygen concentrators. Such regulatory milestones strengthen manufacturers' portfolios, as seen with Inogen's Rove series.

M&A activities like mergers, acquisitions, and partnerships facilitate geographic expansion and market entry for companies. For example, React Health, a player in medical device development, manufacturing, and distribution, acquired Invacare's Respiratory line in February 2023. This strategic move bolsters React Health's market standing, broadens its product offerings, and enhances its ability to serve a wider customer base.

“The addition of the Invacare product line to React Health’s Respiratory offering further strengthens our commitment to providing a full complement of products and services to treat chronic disease states in the home setting. We look forward to welcoming Invacare’s customers and patients to the React Health family.”

-Clint Geffert, President of Commercial Operations at React Health

The impact of regulations on the market is high. The industry is significantly influenced by various regulations, which play a critical role in shaping the growth, innovation, and operational processes of oxygen concentrators. The regulatory framework for oxygen concentrators represents a significant barrier, particularly in terms of regulatory stringency. Companies such as Invacare Corporation and Philips have encountered prolonged consent decrees from the U.S. FDA, illustrating the stringent regulatory environment in the U.S. market.

The regional expansion plays a key role in driving the growth of the North American market by fostering collaboration, access to diverse datasets, and talent pools across regions. It enables companies to tap into new markets, leverage local expertise, comply with region-specific regulations, and gain insights from different healthcare systems, ultimately driving innovation and accelerating the adoption of oxygen concentrators.

Products Insights

The fixed concentrators segment led the market with the largest revenue market share of 53.7% in 2024. Factors such as a higher oxygen output capacity, cost-effectiveness, and widespread adoption in home healthcare settings. Their ability to deliver continuous oxygen flow for patients with chronic respiratory conditions makes them the preferred choice, especially for long-term therapy, contributing to their dominant market share.

The portable oxygen concentrators (POCs) segment is anticipated to witness the fastest CAGR over the forecast period owing to the increasing need for portable medical oxygen concentrators, especially among mobile patients seeking out-of-home solutions. Companies are actively pursuing opportunities to expand in this market segment. For instance, in June 2022, Carire launched a new portable oxygen concentrator, LifeStyle, in the U.S. market. This product has substantially improved the quality of life for oxygen users worldwide by providing a more convenient and reliable oxygen source.

Application Insights

The home care segment led the market with the largest revenue in 2024 and is projected to experience the fastest CAGR during the forecast period. The growth can be attributed to the rising adoption of Long-Term Oxygen Therapy (LTOT) devices in home settings, the availability of a wide range of home oxygen therapy devices (including Liquid Oxygen systems and portable concentrators), and the shifting preferences of patients towards receiving treatment at home.

The non-homecare segment is expected to exhibit a moderate CAGR over the forecast period, driven by the increased adoption of oxygen therapy in hospitals and clinics. Moreover, an increasing number of hospital admissions due to respiratory diseases contributes to the segment’s growth.

Technology Insights

The continuous flow segment accounted for the largest revenue share of 55.5% in 2024. This segment's dominance can be attributed to the increasing prevalence of long-term respiratory disorders, including asthma, COPD, bronchiectasis, and chronic sinusitis. Continuous flow technology is also widely used in residential and military applications, providing a safer alternative to storing oxygen under pressure. 

The pulse flow technology segment is expected to experience the fastest CAGR during the forecast period. The growth is driven by the advantages offered by pulse flow technology, including high mobility, lightweight design, and suitability for patients with active lifestyles. Pulse flow technology is particularly beneficial for treating respiratory conditions that require a lower oxygen delivery rate per minute. It is extensively used in portable oxygen concentrators (POCs).

Country Insights

U.S. Oxygen Concentrators Market Trends

The U.S. oxygen concentrators market dominated the North American region due to its significant investment in R&D, advanced healthcare infrastructure, access to the newest technology, and new product launches. According to the analyzed Medicare claims data, the Medicare penetration rate for portable oxygen concentrators (POCs) in the U.S. has steadily risen. For instance, in 2021, the POC penetration was 22.0%, while that of stationary was 17%. This is a developing trend favoring portable oxygen concentrators (POCs) over fixed oxygen concentrators and fueling market expansion. Government support, such as the Federal Aviation Administration's (FAA) approval of portable concentrators during plane travel, further drives the region's growth.

Key North America Oxygen Concentrator Companies Insights

Key players operating in the North America oxygen concentrator market are undertaking various initiatives to strengthen their presence and increase the reach of their products and services. Strategies such as expansion activities and partnerships are key in propelling the market growth.

Recent Developments

• In January 2025, Caire launched IntenOxy 5, a stationary oxygen concentrator in the U.S. and Puerto Rico. This delivers around 95.5% oxygen concentration and operates efficiently with low power consumption.

“The IntenOxy 5 Stationary Oxygen Concentrator has been an excellent addition to our oxygen therapy portfolio. The unit is a key component to how our DME and HME customers serve their respiratory patients, providing them with an at-home device that delivers the oxygen they need as they navigate activities of daily living,”

-Ken Hosako, president and CEO of Caire.

• In July 2023, VARON launched a new portable oxygen concentrator VP-2 to the VP series of the company. This concentrator aims to provide efficient and reliable oxygen therapy regardless of their location.

Our goal is to make oxygen therapy more accessible by providing reliable, efficient, and affordable solutions for anyone in need. With VP-2 coming out, we believe we are much closer to the goal."

- Darren Wang, CEO of VARON

• In July 2023, Canta Medical introduced an entire oxygen product range at the FIME 2023 United States. FIME 2023 is one of the largest international medical exhibitions for the U.S. healthcare market. It attracts over 10,000 healthcare participants and hosts over 500 medical device manufacturers and distributors.

• In April 2022, CAIRE launched LifeStyle, a portable oxygen concentrator for improving the quality of life for oxygen concentrator uses.

“Pioneering the first portable oxygen concentrator has long been both a point of pride, and an ongoing incentive to continue to innovate and develop those technologies that will ensure clinically efficacious oxygen delivery and an improved quality of life for all of our users around the world,”

-said Earl Lawson, CEO of CAIRE Inc.

North America Oxygen Concentrator Market Report Scope

North America Oxygen Concentrator Market Report Segmentation

This report forecasts volume & revenue growth at the regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the North America oxygen concentrator market report on the basis of product, application, technology, and country.

• Products Outlook (Volume, Unit 000'; Revenue, USD Million, 2021 - 2033)

  • Portable Medical Oxygen Concentrators

  • Fixed Medical Oxygen Concentrators

• Application Outlook (Volume, Unit 000'; Revenue, USD Million, 2021 - 2033)

  • Home Care

  • Non-home Care

• Technology Outlook (Volume, Unit 000'; Revenue, USD Million, 2021 - 2033)

  • Continuous Flow

  • Pulse Flow

• Country Outlook (Volume, Unit 000'; Revenue, USD Million, 2021 - 2033)

  • U.S

  • Canada

  • Mexico